Argent BioPharma Limited

A$0.02As of Sun 8 Nov 2026, 12:00 UTC
ASX:RGTHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (53.57%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.51
PE TTM —
TSR TTM (70.67%)
Mkt cap A$2.593M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0263
19.63%
70.62%
Hold 3|6|11|10|8
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
5.60%
10.62%
25.75%
14.82%
Revenue$M
0.179
0.178
0.178
0.178
1.56%
2.41%
2.33%
1.61%
Peers (US$1.781M)
Cap (US$)
PE
2.550M
—
1.616M
—
Capital
TTM
5Y
10Y
Leveragex
1.408
6.777
5.622
EBIT/Intx
0.453
0.235
0.221
Own earn%
20.59
29.40
26.07
Sh yield%
54.50
10.25
10.12
Owners
Insiders/Inst%
0.83
55.43
Short interest%
0.94
SBC / revenue%
5.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
13–22
$1 testx
—
Incr. ROIC%
4